BusinessDermira Completes Patient Enrollment for Third CIMZIA® (certolizumab pegol) Phase 3 Clinical Trial in Psoriasis Program and Updates Guidance for Release of Topline DataBy Nasdaq OMXJan 8, 2016, 6:00 AM UTC
BusinessDermira Provides DRM01 and DRM04 Development Program UpdatesBy Nasdaq OMXJan 7, 2016, 9:05 PM UTC
